生产企业:Ionis Pharmaceuticals
Zanvastro is an antisense oligonucleotide (ASO) that works by reducing glial fibrillary acidic protein (GFAP), the toxic accumulation of astrocytes in the brain that leads to the creation of Rosenthal fibers which disrupt neurological function.
Zanvastro (zilganersen) is indicated for the treatment of pediatric and adult patients with Alexander disease, a rare, progressive and often fatal neurological disorder that can affect motor, cognitive, autonomic and gastrointestinal function.
共 1 项相关疾病
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
未检索到以该名称命名的专利
专利文献通常使用化学名或研发代号指代药物,而非通用名;且专利申请在提交约 18 个月后才公开,较新的药物可能尚未出现在这里。